These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15817272)

  • 21. Striatal dopamine-glutamate interactions reflected in substantia nigra reticulata firing.
    Timmerman W; Westerhof F; van der Wal TI; Westerink BH
    Neuroreport; 1998 Dec; 9(17):3829-36. PubMed ID: 9875713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra.
    Costa G; Abin-Carriquiry JA; Dajas F
    Brain Res; 2001 Jan; 888(2):336-342. PubMed ID: 11150495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
    Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
    J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra.
    Sengstock GJ; Olanow CW; Dunn AJ; Barone S; Arendash GW
    Exp Neurol; 1994 Nov; 130(1):82-94. PubMed ID: 7529713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra.
    Smith JA; Leslie FM; Broide RS; Loughlin SE
    Neuroscience; 1993 Aug; 55(4):935-51. PubMed ID: 8232904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Striatal dopamine and glutamate release: effects of intranigral injections of substance P.
    Reid MS; Herrera-Marschitz M; Kehr J; Ungerstedt U
    Acta Physiol Scand; 1990 Dec; 140(4):527-37. PubMed ID: 1707211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a striatal NMDA receptor modulation of nigral glutamate release. A dual probe microdialysis study in the awake freely moving rat.
    Morari M; Sbrenna S; Marti M; O'Connor WT; Bianchi C; Fuxe K; Beani L
    Eur J Neurosci; 1998 May; 10(5):1716-22. PubMed ID: 9751143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of repeated administration of l-DOPA and apomorphine on circling behavior and striatal dopamine formation.
    Brannan T; Prikhojan A; Yahr MD
    Brain Res; 1998 Feb; 784(1-2):148-53. PubMed ID: 9518585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reciprocal interaction between glutamate and dopamine in the pars reticulata of the rat substantia nigra: a microdialysis study.
    Rosales MG; Martinez-Fong D; Morales R; Nuñez A; Flores G; Góngora-Alfaro JL; Flóran B; Aceves J
    Neuroscience; 1997 Oct; 80(3):803-10. PubMed ID: 9276495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
    Roger LJ; Breese GR; Morell P
    Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rotenone increases glutamate-induced dopamine release but does not affect hydroxyl-free radical formation in rat striatum.
    Leng A; Feldon J; Ferger B
    Synapse; 2003 Dec; 50(3):240-50. PubMed ID: 14515342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis.
    Gerfen CR; McGinty JF; Young WS
    J Neurosci; 1991 Apr; 11(4):1016-31. PubMed ID: 1707092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholinergic stimulation of rostral and caudal substantia nigra pars compacta produces opposite effects on circling behavior and striatal dopamine release measured by brain microdialysis.
    Hernández-López S; Góngora-Alfaro JL; Martínez-Fong D; Rosales MG; Aceves J
    Neuroscience; 1994 Sep; 62(2):441-7. PubMed ID: 7830890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease.
    Oiwa Y; Sanchez-Pernaute R; Harvey-White J; Bankiewicz KS
    J Neurosurg; 2003 Jan; 98(1):136-44. PubMed ID: 12546362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.
    Heeringa MJ; Abercrombie ED
    J Neurochem; 1995 Jul; 65(1):192-200. PubMed ID: 7790860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single unit responses of substantia nigra pars reticulata neurons to apomorphine: effects of striatal lesions and anesthesia.
    Waszczak BL; Lee EK; Ferraro T; Hare TA; Walters JR
    Brain Res; 1984 Jul; 306(1-2):307-18. PubMed ID: 6466980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
    Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP
    Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.